Related Experiment Video
Updated: Apr 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
A generation at risk: young investigators and the future of the biomedical workforce
1President, Johns Hopkins University, Baltimore, MD 21287 president@jhu.edu.
Abstract:
A number of distressing trends, including a decline in the share of key research grants going to younger scientists, as well as a steady rise in the age at which investigators receive their first funding, are now a decades-long feature of the US biomedical research workforce. Working committees have proposed recommendations, policy makers have implemented reforms, and yet the trajectory of our funding regime away from young scientists has only worsened. An investigation of some of the major factors and their geneses at play in explaining the increasing average age to first RO1 is presented. Recommendations related to funding, peer review, career paths, and the university-government partnership are provided.
Related Concept Videos
Preclinical Development: Overview
Investigation of Disease Outbreaks
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Microorganisms in Medicine and Therapeutics
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethics in Research

